Page results
-
This information has been written for patients who have been referred for pelvic radiotherapy for a gynaecological cancer.
-
This page has been written for patients who are having a course of radiotherapy for a brain tumour called a meningioma.
-
This information is for patients who are about to start a course of radiotherapy to the prostate/prostate bed.
-
This information page has been written to help answer some of the questions you may have about brain metastases, and their treatment with this specialised radiotherapy technique.
-
This page has been written for patients who are having radiotherapy for bone pain.
-
Dr Victoria Grandage is a consultant haematologist with research interests in acute myeloid leukaemia, non-malignant haematology, bone marrow transplantation and the late effects of cancer treatment.
-
Brooke Robinson tells us what it is like to work to in neuroradiography at the National Hospital for Neurology and Neurosurgery.
-
Information about total penectomy and perineal urethrostomy for patients referred to UCLH.
-
Info about our regular, online origami club for people under the care of UCLH for cancer or a blood condition
-
This page provides information for employers, teachers, special needs education coordinators (SENCo) and other professionals who work alongside someone with Galactosaemia.
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer